CJC-1295 Australia

CJC-1295 (no DAC) Australia. CJC-1295 (no DAC) — also catalogued as Mod GRF (1-29) — is a 30-residue stabilised analogue of growth-hormone-releasing hormone (GHRH) studied in laboratory research as the standard standalone GHRH research peptide. The "no DAC" suffix indicates the form without the drug-affinity-complex modification. The Elite AU Peptides CJC-1295 (no DAC) is independently HPLC-tested by Janoshik; the certificate of analysis is published on this page and in the lab-reports library, with the measured number and an independently verifiable Janoshik key.

Supplied in 5 mg and 10 mg lyophilised vials, AU-domestic, AUD pricing. Distinct from the co-lyophilised CJC-1295 (no DAC) + Ipamorelin research blend — this product is the standalone GHRH. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption, not a therapeutic good, not TGA-approved.

CJC-1295 (no DAC) (CAS 863288-34-0; molecular formula C152H252N44O42, average molecular weight ≈ 3368 g/mol) is a 30-residue synthetic analogue of the native hGRF(1-29) sequence — Mod GRF (1-29). It carries four stabilising substitutions on the GHRH(1-29) backbone (including D-Ala at position 2) plus a C-terminal amide, which slow enzymatic degradation while retaining GHRH-receptor-binding activity in research models.

The value of that backbone chemistry is well characterised: Soule and colleagues (The Journal of Clinical Endocrinology & Metabolism, 1994) showed that incorporating D-Ala2 into GHRH(1-29) increases half-life and lowers metabolic clearance by blocking dipeptidyl-peptidase cleavage — the substitution central to the Mod GRF (1-29) backbone.

The "no DAC" label distinguishes this form from the DAC (drug-affinity-complex) variant: Jetté and colleagues (Endocrinology, 2005) identified CJC-1295 as an albumin-bioconjugated hGRF(1-29) analogue with plasma persistence extending over days, and Teichman and colleagues (The Journal of Clinical Endocrinology & Metabolism, 2006) reported the multi-day half-life of that DAC molecule. The no-DAC form referenced here carries the stabilising backbone substitutions but not the albumin-binding DAC group, so it is the shorter-acting, canonical reference version in GHRH research.

In research literature CJC-1295 (no DAC) is most frequently studied alongside a GHRP (typically Ipamorelin) — the canonical research pairing combines a GHRH-analogue and a GHRP because the two receptor classes act on distinct, convergent points of the same somatotrophic-axis research model. See the CJC-1295 (no DAC) + Ipamorelin research blend product page for the co-lyophilised research-stack variant, and the Ipamorelin standalone product page for the GHRP partner.

The information provided here is a research-reference summary only. Elite AU Peptides makes no medical, therapeutic, performance, or human-use claim about this product. CJC-1295 (no DAC) is not TGA-approved, is not a therapeutic good, and is supplied strictly for in-vitro and laboratory research use only. Researchers should consult the primary peer-reviewed literature for receptor-binding affinities, pharmacokinetic data, and protocol-specific reference values.

Reconstitute the lyophilised CJC-1295 (no DAC) vial with bacteriostatic water for laboratory handling. Add the diluent slowly down the vial wall and swirl gently rather than shaking. The required volume depends on the protocol’s downstream assay requirements — a 5 mg vial reconstituted in 2.5 mL of bacteriostatic water yields a 2 mg/mL working stock. Adjust per protocol.

Store the lyophilised powder at −20°C, desiccated and protected from light; once reconstituted, store refrigerated at 2–8°C and use within the documented research window, or aliquot and freeze to avoid repeated freeze-thaw cycles. Tamper-evident packaging; the batch label is the canonical reference for the certificate of analysis published in the lab-reports library.

Shop bacteriostatic water

Australia only. Free shipping over $100. Orders placed before 12pm AEST are dispatched the same business day from Australia.

30-day returns on unused product in original packaging, with prior approval.